ClinicalTrials.Veeva

Menu
A

Asociacion Civil Selva Amazonica | Iquitos, Peru

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Emtricitabine
JNJ-64281802
Lenacapavir
Tenofovir Disoproxil Fumarate
Mebendazole

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 10 total trials

A Study of JNJ-64281802 for the Prevention of Dengue Infection

The purpose of this study is to evaluate the prophylactic effect of JNJ-64281802 with respect to the prevention of laboratory-confirmed dengue virus...

Enrolling
Dengue
Drug: Placebo
Drug: JNJ-64281802

The purpose of this study is to evaluate the efficacy, immunogenicity and safety of the 9-valent human papillomavirus (9vHPV) vaccine in men 20 to 45...

Active, not recruiting
Papillomavirus Infections
Biological: 9vHPV Vaccine
Other: Placebo (Saline for Injection)

The goal of this clinical study is to test how well the study drug, lenacapavir (LEN), works in preventing the risk of HIV.

Active, not recruiting
Pre-Exposure Prophylaxis of HIV Infection
Drug: PTM F/TDF
Drug: Placebo SC LEN

Trial sponsors

Janssen (J&J Innovative Medicine) logo
Merck Sharp & Dohme (MSD) logo
Gilead Sciences logo
Janssen (J&J Innovative Medicine) logo
McGill University logo
National Institute of Allergy and Infectious Diseases (NIAID) logo
A
H

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems